Incannex Healthcare Inc
IXHL0.428USD
+0.043+11.02%
시장 운영 시간 （ET）시세는 15분 지연됩니다
7.61M시가총액
손실P/E TTM
자세한 내용은 Incannex Healthcare Inc 회사
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.
회사 정보
종목 코드 IXHL
회사 이름Incannex Healthcare Inc
상장일Mar 18, 2022
CEOMr. Joel Latham
직원 수9
유형Ordinary Share
회계 연도 종료Mar 18
주소8 Century Circuit
도시
증권 거래소NASDAQ Capital Market Consolidated
국가Australia
우편 번호2153
전화61409840786
웹사이트
종목 코드 IXHL
상장일Mar 18, 2022
CEOMr. Joel Latham
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
1.24M
-21.24%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
744.72K
-3.25%
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
639.55K
--
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
245.85K
-9.23%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
17.93K
-89.40%
Mr. Troy Valentine
Mr. Troy Valentine
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Luigi M. (Lou) Barbato, M.D.
Dr. Luigi M. (Lou) Barbato, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Robert B. Clark
Mr. Robert B. Clark
Non-Executive Independent Director
Non-Executive Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
1.24M
-21.24%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
744.72K
-3.25%
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
639.55K
--
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
245.85K
-9.23%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
17.93K
-89.40%
Mr. Troy Valentine
Mr. Troy Valentine
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
수익 분석
FY2025Q1
FY2024
FY2024Q4
FY2022
데이터 없음
지역별USD
이름
수익
비율
Australia
74.00K
0.00%
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Wed, Jul 16
마지막 업데이트: Wed, Jul 16
주주
주주 유형
주주
주주
비율
Great Point Capital LLC
6.55%
L1 Capital Global Opportunities Master Fund Ltd.
6.55%
S.H.N. Financial Investments Ltd
6.55%
Latham (Joel)
4.22%
Valentine (Troy Robert)
2.95%
Other
73.17%
주주
주주
비율
Great Point Capital LLC
6.55%
L1 Capital Global Opportunities Master Fund Ltd.
6.55%
S.H.N. Financial Investments Ltd
6.55%
Latham (Joel)
4.22%
Valentine (Troy Robert)
2.95%
Other
73.17%
주주 유형
주주
비율
Corporation
13.11%
Individual Investor
13.03%
Investment Advisor
8.09%
Hedge Fund
0.35%
Research Firm
0.18%
Investment Advisor/Hedge Fund
0.03%
Other
65.22%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
39
10.24M
34.78%
+3.35M
2025Q1
36
6.86M
34.69%
+1.54M
2024Q4
34
5.22M
29.25%
-10.87K
2024Q3
35
5.23M
32.43%
+928.92K
2024Q2
32
5.32M
33.29%
+935.04K
2024Q1
33
4.38M
27.39%
+2.50M
2023Q4
26
4.32M
27.01%
+2.81M
2023Q3
13
32.37K
0.05%
-34.33K
2023Q2
11
12.21K
0.02%
-63.09K
2023Q1
10
20.53K
0.03%
-60.83K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Great Point Capital LLC
1.93M
6.55%
+1.93M
--
Apr 09, 2025
L1 Capital Global Opportunities Master Fund Ltd.
1.93M
6.55%
+460.27K
+31.34%
Apr 09, 2025
S.H.N. Financial Investments Ltd
1.93M
6.55%
+1.93M
--
Apr 09, 2025
Latham (Joel)
1.24M
4.22%
-335.00K
-21.24%
Apr 09, 2025
Valentine (Troy Robert)
869.01K
2.95%
-167.50K
-16.16%
Apr 09, 2025
Anastassov (George)
744.72K
2.53%
-25.00K
-3.25%
Apr 09, 2025
Changoer (Lekhram)
639.55K
2.17%
--
--
Apr 09, 2025
AdvisorShares Investments, LLC
295.03K
1%
+129.54K
+78.27%
Mar 31, 2025
Widdows (Peter)
245.85K
0.84%
-25.00K
-9.23%
Apr 09, 2025
Citadel Advisors LLC
102.87K
0.35%
+102.87K
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
AdvisorShares Psychedelics ETF
0.73%
Amplify Alternative Harvest ETF
0%
AdvisorShares Psychedelics ETF
비율0.73%
Amplify Alternative Harvest ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
